07:00 , Jul 16, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Autism Benzodiazepine receptor (peripheral)-associated protein 1 (BZRAP1); MAM domain containing glycosylphosphatidylinositol anchor 2 (MDGA2); contactin 4 (CNTN4); neurexin 1 (NRXN1) A genomewide study suggests that...
07:00 , May 7, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Autism Astrotactin 2 (ASTN2); constitutive photomorphogenic 1 (RFWD2; COP1); contactin 4 (CNTN4); F-box protein 40 (FBXO40); neuroligin 1 (NLGN1); neurexin 1...